Matsukuma Karen, Olson Kristin A, Gui Dorina, Gandour-Edwards Regina, Li Yueju, Beckett Laurel
Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, CA, USA.
Department of Public Health Sciences, Division of Biostatistics, University of California Davis, Davis, CA, USA.
Mod Pathol. 2017 Apr;30(4):620-629. doi: 10.1038/modpathol.2016.225. Epub 2017 Jan 13.
A common problem in the assessment of Ki67 proliferative index in well-differentiated gastrointestinal neuroendocrine tumors is distinguishing tumor from non-tumor. This is because background stromal lymphocytes, entrapped non-neoplastic glands, and the delicate vascular network characteristic of neuroendocrine tumors frequently contain a subset of proliferating cells. Furthermore, in small biopsies, crush and cautery artifact can alter the morphologic appearance of tumor cells, making the Ki67 proliferative index more difficult to assess. To address these issues, we developed a synaptophysin-Ki67 double stain using a commercially available immunohistochemistry kit, allowing simultaneous visualization of tumor and proliferating nuclei. To test this method, three gastrointestinal pathologists individually graded 50 gastrointestinal neuroendocrine tumors first using synaptophysin-Ki67 double-stained slides and then, after a washout period, using Ki67-only stained slides (along with routine hematoxylin- and eosin-stained slides). Interobserver agreement on Ki67 proliferative index was moderate using the Ki67-only stained slides (intraclass correlation 0.51, 95% confidence interval: 0.35-0.66) and improved using the synaptophysin-Ki67 double stain (intraclass correlation 0.79, 95% confidence interval: 0.69-0.86). Similarly, interobserver agreement on tumor grade was fair with Ki67-only stained slides (κ=0.39, P<0.001) and improved with the double stain (κ=0.58, P<0.001). Analysis of individual pathologists' scores revealed that fewer total number of tumor cells counted correlated with higher grade designation and appeared to contribute to grade discordance. In tumors cited as particularly challenging to assess by the pathologists, three of four tumors were grade discordant with the Ki67-only stain, whereas all four tumors were grade concordant with the synaptophysin-Ki67 stain. The synaptophysin-Ki67 double stain is the first technique to address specifically the histomorphologic challenges of evaluating Ki67 proliferative index in well-differentiated gastrointestinal neuroendocrine tumors. Although further validation is needed, this study provides evidence that the synaptophysin-Ki67 double stain can improve interobserver agreement.
在评估高分化胃肠道神经内分泌肿瘤的Ki67增殖指数时,一个常见问题是区分肿瘤细胞和非肿瘤细胞。这是因为背景基质淋巴细胞、包埋的非肿瘤性腺管以及神经内分泌肿瘤特有的精细血管网络中常常含有一部分增殖细胞。此外,在小活检标本中,挤压和烧灼伪像会改变肿瘤细胞的形态,使得Ki67增殖指数更难评估。为了解决这些问题,我们使用市售免疫组织化学试剂盒开发了一种突触素-Ki67双重染色法,可同时显示肿瘤细胞和增殖细胞核。为了测试该方法,三位胃肠道病理学家首先使用突触素-Ki67双重染色玻片对50例胃肠道神经内分泌肿瘤进行分级,然后在洗脱期后,使用仅Ki67染色的玻片(以及常规苏木精和伊红染色玻片)进行分级。仅使用Ki67染色玻片时,观察者间对Ki67增殖指数的一致性为中等(组内相关系数0.51,95%置信区间:0.35 - 0.66),而使用突触素-Ki67双重染色时一致性得到改善(组内相关系数0.79,95%置信区间:0.69 - 0.86)。同样,仅使用Ki67染色玻片时,观察者间对肿瘤分级的一致性一般(κ = 0.39,P < 0.001),而使用双重染色时得到改善(κ = 0.58,P < 0.001)。对个体病理学家评分的分析显示,计数的肿瘤细胞总数越少与更高的分级相关,且似乎导致了分级不一致。在病理学家认为特别难以评估的肿瘤中,四分之三的肿瘤在仅使用Ki67染色时分级不一致,而所有四个肿瘤在突触素-Ki67染色时分级一致。突触素-Ki67双重染色是第一种专门解决评估高分化胃肠道神经内分泌肿瘤Ki67增殖指数的组织形态学挑战的技术。尽管需要进一步验证,但本研究提供了证据表明突触素-Ki67双重染色可改善观察者间的一致性。